Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 79

1.

Hello out there...is anybody listening?

DeFilippis RA, Tlsty TD.

Cancer Discov. 2012 Dec;2(12):1084-6. doi: 10.1158/2159-8290.CD-12-0434.

2.

Identification of luminal breast cancers that establish a tumor-supportive macroenvironment defined by proangiogenic platelets and bone marrow-derived cells.

Kuznetsov HS, Marsh T, Markens BA, Castaño Z, Greene-Colozzi A, Hay SA, Brown VE, Richardson AL, Signoretti S, Battinelli EM, McAllister SS.

Cancer Discov. 2012 Dec;2(12):1150-65. doi: 10.1158/2159-8290.CD-12-0216. Epub 2012 Aug 15.

3.

[The detection of tumor cells in the bone marrow, peripheral blood and leukapheresis products in breast carcinoma patients].

Zhong XY.

Dtsch Med Wochenschr. 2000 Jul 7;125(27):840-4. Review. German. No abstract available.

PMID:
10929540
4.

Comparison of HER2 Expression in Primary Tumor and Disseminated Tumor Cells in the Bone Marrow of Breast Cancer Patients.

Rack B, Zombirt E, Trapp E, Jückstock J, Andergassen U, Neugebauer J, Kost B, Weissenbacher T, Jeschke U, Schindlbeck C, Janni W, Alunni-Fabbroni M.

Oncology. 2016;90(4):232-8. doi: 10.1159/000442986. Epub 2016 Mar 4.

PMID:
26937631
5.

[Cytokeratin-19 in diagnosis of bone marrow metastases in patients with breast cancer - clinical results].

Iovtchev I, Gŭlŭbova M, Vlaĭkova T, Vidolov P.

Khirurgiia (Sofiia). 2007;(3):43-5. Bulgarian.

PMID:
18437110
6.

Intravascular cell-to-cell adhesive interactions and bone metastasis.

Glinsky VV.

Cancer Metastasis Rev. 2006 Dec;25(4):531-40. Review.

PMID:
17171440
8.

Human mesenchymal stem cells from bone marrow express tumor endothelial and stromal markers.

Bagley RG, Weber W, Rouleau C, Yao M, Honma N, Kataoka S, Ishida I, Roberts BL, Teicher BA.

Int J Oncol. 2009 Mar;34(3):619-27.

PMID:
19212666
9.

The proportion of reticulated platelets is higher in bone marrow than in peripheral blood in haematological patients.

Stohlawetz P, Schulenburg A, Stiegler G, Panzer S, Höcker P, Kalhs P, Schwarzinger I, Müllauer L, Simonitsch I, Geissler K, Jilma B.

Eur J Haematol. 1999 Oct;63(4):239-44.

PMID:
10530412
10.

Evaluation of bone marrow in breast cancer patients: prediction of clinical outcome and response to therapy.

Braun S, Vogl FD, Janni W, Marth C, Schlimok G, Pantel K.

Breast. 2003 Dec;12(6):397-404. Review.

PMID:
14659112
11.

Isolation and characterization of a metastatic hybrid cell line generated by ER negative and ER positive breast cancer cells in mouse bone marrow.

Mukhopadhyay KD, Bandyopadhyay A, Chang TT, Elkahloun AG, Cornell JE, Yang J, Goins BA, Yeh IT, Sun LZ.

PLoS One. 2011;6(6):e20473. doi: 10.1371/journal.pone.0020473. Epub 2011 Jun 1.

12.
13.

Disseminated tumor cells in breast cancer: detection, characterization and clinical relevance.

Wölfle U, Müller V, Pantel K.

Future Oncol. 2006 Aug;2(4):553-61. Review.

PMID:
16922621
14.

Angiogenesis in the bone marrow of patients with breast cancer.

Chavez-Macgregor M, Aviles-Salas A, Green D, Fuentes-Alburo A, Gómez-Ruiz C, Aguayo A.

Clin Cancer Res. 2005 Aug 1;11(15):5396-400.

15.

Bone-marrow analysis predicts breast-cancer recurrence.

Habeck M.

Mol Med Today. 2000 Jul;6(7):256-7. No abstract available.

PMID:
10859556
16.

Interactions between breast cancer cells and bone marrow derived cells in vitro define a role for osteopontin in affecting breast cancer cell migration.

Koro K, Parkin S, Pohorelic B, Yang AD, Narendran A, Egan C, Magliocco A.

Breast Cancer Res Treat. 2011 Feb;126(1):73-83. doi: 10.1007/s10549-010-0889-9. Epub 2010 Apr 17.

PMID:
20401631
17.

Microenvironmental regulation of epithelial-mesenchymal transitions in cancer.

Gao D, Vahdat LT, Wong S, Chang JC, Mittal V.

Cancer Res. 2012 Oct 1;72(19):4883-9. doi: 10.1158/0008-5472.CAN-12-1223. Epub 2012 Sep 20. Review.

18.

HER2 status on persistent disseminated tumor cells after adjuvant therapy may differ from initial HER2 status on primary tumor.

Krawczyk N, Banys M, Neubauer H, Solomayer EF, Gall C, Hahn M, Becker S, Bachmann R, Wallwiener D, Fehm T.

Anticancer Res. 2009 Oct;29(10):4019-24.

19.

Platelets secrete stromal cell-derived factor 1alpha and recruit bone marrow-derived progenitor cells to arterial thrombi in vivo.

Massberg S, Konrad I, Schürzinger K, Lorenz M, Schneider S, Zohlnhoefer D, Hoppe K, Schiemann M, Kennerknecht E, Sauer S, Schulz C, Kerstan S, Rudelius M, Seidl S, Sorge F, Langer H, Peluso M, Goyal P, Vestweber D, Emambokus NR, Busch DH, Frampton J, Gawaz M.

J Exp Med. 2006 May 15;203(5):1221-33. Epub 2006 Apr 17.

20.

Breast cancer metastatic potential: correlation with increased heterotypic gap junctional intercellular communication between breast cancer cells and osteoblastic cells.

Kapoor P, Saunders MM, Li Z, Zhou Z, Sheaffer N, Kunze EL, Samant RS, Welch DR, Donahue HJ.

Int J Cancer. 2004 Sep 20;111(5):693-7.

Supplemental Content

Support Center